Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-26T07:47:32.487Z Has data issue: false hasContentIssue false

Chapter 6 - The Relevance of the Anti-Müllerian Hormone in Polycystic Ovary Syndrome Diagnosis and Management

Published online by Cambridge University Press:  13 May 2022

By
Martina Capuzzo  and
Antonio La Marca
Edited by
Gabor T. Kovacs ,
Bart Fauser  and
Richard S. Legro
Gabor T. Kovacs
Affiliation:
Monash University, Melbourne, Australia
Bart Fauser
Affiliation:
University Medical Center, Utrecht, Netherlands
Richard S. Legro
Affiliation:
Penn State Medical Center, Hershey, PA, USA
Get access

Summary

Anti-Müllerian hormone (AMH) has recently been proposed as a diagnostic marker for polycystic ovary syndrome (PCOS) instead of polycystic ovarian morphology (PCOM) seen on ultrasound. As serum AMH level reflects excess small follicles not visible on ultrasonography, AMH level would theoretically be more accurate than PCOM as a diagnostic marker. Its value is significantly higher in PCOS patients than in normal women; its high levels are also considered to play an important role in the pathogenesis of the disorder, accounting for anovulation in PCOS patients. Nevertheless, its use is still not recommended by the international guidelines as an alternative for detecting PCOM or as a single test result for the diagnosis of PCOS. Its potential clinical applications in PCOS patients are currently the characterization of the severity of the syndrome and in deciding hormone doses for ovarian stimulation treatments. An international standard is needed to standardize the existing assays for AMH calibration before diagnostic cutoffs can be determined and before AMH use as a diagnostic marker can be considered meaningful.

Keywords

polycystic ovary syndrome (PCOS)anti-Müllerian hormone (AMH)ovarian reservediagnostic markeranovulation
Type
Chapter
Information
Polycystic Ovary Syndrome , pp. 52 - 57
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Geisthövel, F. and Rabe, T. The ESHRE/ASRM consensus on polycystic ovary syndrome (PCOS): An extended critical analysis. Reprod Biomed Online 2007; 14(4): 522–535. https://doi.org/10.1016/s1472-6483(10)60902-9CrossRefGoogle ScholarPubMed
Visser, J. A. and Themmen, A. P. Anti-Müllerian hormone and folliculogenesis. Mol Cell Endocrinol 2005; 234(1–2): 81–86. https://doi.org/10.1016/j.mce.2004.09.008CrossRefGoogle ScholarPubMed
La Marca, A., Pati, M., Orvieto, R., Stabile, G., Carducci Artenisio, A. and Volpe, A. Serum anti-Müllerian hormone levels in women with secondary amenorrhea. Fertil Steril 2006; 85(5): 1547–1549. https://doi.org/10.1016/j.fertnstert.2005.10.057Google Scholar
Oh, S. R., Choe, S. Y. and Cho, Y. J. Clinical application of serum anti-Müllerian hormone in women. Clin Exp Reprod Med 2019; 46(2): 50–59. https://doi.org/10.5653/cerm.2019.46.2.50Google Scholar
Sacchi, S., D’Ippolito, G., Sena, P. et al. The anti-Müllerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH. J Assist Reprod Genet 2016; 33(1): 95–100. https://doi.org/10.1007/s10815-015-0615-yGoogle Scholar
La Marca, A., Morgante, G., Palumbo, M., Cianci, A., Petraglia, F. and De Leo, V. Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome. Fertil Steril 2002; 78(6): 1234–1239. https://doi.org/10.1016/s0015-0282(02)04346-7Google Scholar
Cimino, I., Casoni, F., Liu, X. et al. Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat Commun 2016; 7: 10055. https://doi.org/10.1038/ncomms10055CrossRefGoogle ScholarPubMed
Van Rooij, I. A., Broekmans, F. J., Scheffer, G. J. et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal study. Fertil Steril 2005; 83(4): 979–987. https://doi.org/10.1016/j.fertnstert.2004.11.029Google Scholar
Anovulatory infertility. The ESHRE Capri Workshop Group. Hum Reprod 1995; 10(6):1549–1553.CrossRefGoogle Scholar
Lie Fong, S., Schipper, I., Valkenburg, O., de Jong, F. H., Visser, J. A. and Laven, J. S. The role of anti-Müllerian hormone in the classification of anovulatory infertility. Eur J Obstet Gynecol Reprod Biol 2015; 186: 75–9. https://doi.org/10.1016/j.ejogrb.2015.01.007CrossRefGoogle ScholarPubMed
Grinspoon, S., Miller, K., Coyle, C. et al. Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab 1999; 84(6): 2049–2055. https://doi.org/10.1210/jcem.84.6.5792Google ScholarPubMed
Vescovi, J. D., Jamal, S. A. and De Souza, M. J. Strategies to reverse bone loss in women with functional hypothalamic amenorrhea: A systematic review of the literature. Osteoporos Int 2008; 19(4): 465–478. https://doi.org/10.1007/s00198-007-0518-6Google Scholar
Wu, C. H., Chen, Y. C., Wu, H. H., Yang, J. G., Chang, Y. J. and Tsai, H. D. Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients. J Assist Reprod Genet 2009; 26(7): 383–389. https://doi.org/10.1007/s10815-009-9332-8Google Scholar
Durlinger, A. L., Visser, J. A. and Themmen, A. P. Regulation of ovarian function: The role of anti Müllerian hormone. Reproduction 2002; 124(5): 601–609. https://doi.org/10.1530/rep.0.1240601CrossRefGoogle ScholarPubMed
Weenen, C., Laven, J. S., Von Bergh, A. R. et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004; 10(2): 77–83. https://doi.org/10.1093/molehr/gah015CrossRefGoogle ScholarPubMed
Van Elburg, A. A., Eijkemans, M. J., Kas, M. J. et al. Predictors of recovery of ovarian function during weight gain in anorexia nervosa. Fertil Steril 2007; 87(4): 902–908. https://doi.org/10.1016/j.fertnstert.2006.11.004Google Scholar
La Marca, A., Pati, M., Orvieto, R., Stabile, G., Carducci Artenisio, A. and Volpe, A. Serum anti-Müllerian hormone levels in women with secondary amenorrhea. Fertil Steril 2006; 85(5): 1547–1549. https://doi.org/10.1016/j.fertnstert.2005.10.057CrossRefGoogle ScholarPubMed
Knauff, E. A., Eijkemans, M. J., Lambalk, C.B. et al. Dutch Premature Ovarian Failure Consortium: Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab 2009; 94(3): 786–792. https://doi.org/10.1210/jc.2008-1818Google Scholar
Méduri, G., Massin, N., Guibourdenche, J. et al. Serum anti-Müllerian hormone expression in women with premature ovarian failure. Hum Reprod 2007; 22(1): 117–123. https://doi.org/10.1093/humrep/del346Google Scholar
Pigny, P., Merlen, E., Robert, Y. et al. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: Relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 2003; 88(12): 5957–5962. https://doi.org/10.1210/jc.2003-030727Google Scholar
Laven, J. S., Mulders, A. G., Visser, J. A., Themmen, A. P., De Jong, F. H. and Fauser, B. C. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 2004; 89(1): 318–323. https://doi.org/10.1210/jc.2003-030932CrossRefGoogle ScholarPubMed
Maciel, G. A., Baracat, E. C., Benda, J. A. et al. Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004; 89(11): 5321–5327. https://doi.org/10.1210/jc.2004-0643Google Scholar
Pellatt, L., Hanna, L., Brincat, M. et al. Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab 2007; 92(1): 240–245. https://doi.org/10.1210/jc.2006-1582Google Scholar
Iliodromiti, S., Kelsey, T. W., Anderson, R. A. and Nelson, S. M. Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. J Clin Endocrinol Metab 2013; 98(8): 3332–3340. https://doi.org/10.1210/jc.2013-1393CrossRefGoogle ScholarPubMed
Dewailly, D., Gronier, H., Poncelet, E. et al. Diagnosis of polycystic ovary syndrome (PCOS): Revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod 2011; 26(11): 3123–3129. https://doi.org/10.1093/humrep/der297Google Scholar
Teede, H. J., Misso, M. L., Costello, M. F. et al. International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod 2018; 33(9): 1602–1618. https://doi.org/10.1093/humrep/dey256. [Erratum in: Hum Reprod 2019; 34(2): 388.]CrossRefGoogle ScholarPubMed
Tal, R., Seifer, D. B., Khanimov, M., Malter, H. E., Grazi, R. V. and Leader, B. Characterization of women with elevated antimüllerian hormone levels (AMH): Correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes. Am J Obstet Gynecol 2014; 211(1): 59.e1–8. https://doi.org/10.1016/j.ajog.2014.02.026Google Scholar
Thomson, R. L., Buckley, J. D., Moran, L. J. et al. The effect of weight loss on anti-Müllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment. Hum Reprod 2009; 24(8): 1976–1981. https://doi.org/10.1093/humrep/dep101Google Scholar
Pellatt, L., Rice, S. and Mason, H. D. Anti-Müllerian hormone and polycystic ovary syndrome: A mountain too high? Reproduction 2010; 139(5): 825–833. https://doi.org/10.1530/REP-09-0415Google Scholar
Carmina, E., Fruzzetti, F. and Lobo, R. A. Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function. Gynecol Endocrinol 2018; 34(4): 301–304. https://doi.org/10.1080/09513590.2017.1395842Google Scholar
Ezoe, K., Ni, X., Kobayashi, T. and Kato, K. Anti-Müllerian hormone is correlated with cumulative live birth in minimal ovarian stimulation with clomiphene citrate: A retrospective cohort study. BMC Pregnancy Childbirth 2020; 20(740). https://doi.org/10.1186/s12884-020-03446-1Google Scholar
Xu, B., Zhou, M., Cheng, M. et al. Transvaginal ovarian drilling followed by controlled ovarian stimulation from the next day improves ovarian response for the poor responders with polycystic ovary syndrome during IVF treatment: A pilot study. Reprod Biol Endocrinol 2020; 18(7). https://doi.org/10.1186/s12958-019-0559-7CrossRefGoogle ScholarPubMed
Tadros, T., Tarasconi, B., Nassar, J., Benhaim, J. L., Taieb, J. and Fanchin, R. New automated antimüllerian hormone assays are more reliable than the manual assay in patients with reduced antral follicle count. Fertil Steril 2016; 106(7): 1800–1806. https://doi.org/10.1016/j.fertnstert.2016.08.045CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×